FANS are becoming a standard! Another step forward in providing top-notch care for our patients with urolithiasis! 1550 HU 20 x 17 mm stone removed in 42 min.
11/13 ClearPetra UAS
8.5 Fr Hawk ureteroscope
@wojciechpiotrk1@bartmalkiewicz@ChorbinskaJ
Our latest SR and MA "Clinical and Oncological Outcomes Following Percutaneous Cryoablation vs. Partial Nephrectomy for Clinical T1 Renal Tumours: Systematic Review and Meta-Analysis" is now available.
@wojciechpiotrk1@bartmalkiewicz@ChorbinskaJ@f_delgiudice
A new tool in our endourological armamentarium: micro-PCNL 4.8 Fr, "all-seeing needle" (MicroPerc®).
No bleeding after calyceal puncture, good visibility, effective lithotripsy.
Viable option in selective cases.
@wojciechpiotrk1@bartmalkiewicz@ChorbinskaJ
RIRS using 10/12 Fr ClearPetra UAS from WellLead Medical Company.
Hard (1550 HU) and large (2.5 x 2 cm) renal pelvis stone dusted in 46 minutes.
Simply a game changer.
@wojciechpiotrk1@ChorbinskaJ@bartmalkiewicz
As the Guest Editors, we are pleased to announce a new Special Issue for Biomedicines entitled "Bladder Cancer: From Pathophysiology to Novel Therapeutic Approaches".
https://t.co/4UsIwTy0Uk
HPV found in 45% of penile tumours treated at Haukeland University Hospital, HPV-16 being most common subtype. 5 yrs CSS 70% in HPV+, 83% in HPV -, not independent predictor for survival. HPV remains a risk factor for penile cancer #EAU23#HPV A0639
MiR371 data on 16 marker-negative stage IIA/B patients (10 seminoma/6 non-seminoma) undergoing primary nsRPLND presented #EAU23, summary by @JoaoPedroLobo89: Metastatic seminoma/non-seminoma in 12 patients, all miR371 positive. MiR371 negative in 3/4 pts without metastases. A0750
RA-VEIL in 67 patients in Rajiv Ghandi Cancer Institute #Deli – comparable LoS between CN+ vs CN- group. 85.8% free of complications. 3yr CSS 70.5% in CN+ vs 100% in CN- likely to reflect disease biology. RA-VEIL option to provide local control in CN+ Abstract: A0642 from #EAU23
From 3276 PeCa pts treated from 1990-2020 in the Netherlands, pts with pT2-4 or pN+ are treated more frequently in expert centers. 5-year relative survival was longer in expert centers (86%) compared to non-expert centers (76%, p<0.001). A0645 by Manon Vreeburg @NKI_nl#EAU23